MARSHALL WACE, LLP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 194 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$190,412
-77.3%
24,506
-87.4%
0.00%
-100.0%
Q4 2022$839,294
-36.8%
194,281
+81.0%
0.00%
-33.3%
Q1 2022$1,329,000
-71.4%
107,318
-47.1%
0.00%
-66.7%
Q4 2021$4,642,000
+1432.0%
202,992
+983.2%
0.01%
+350.0%
Q2 2020$303,00018,7400.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders